VitaNova Biological Inc.

VitaNova Biological Incorporated is a new biotechnology company focusing on the development and implementation of proprietary intellectual property that has proven successful in killing cancer in vitro.  The company was founded in 2014 by two University of Texas at San Antonio alumni, Matthew Gdovin and Greg Espenhover.  

VitaNova Biological Inc. is currently conducting pre-clinical trials using photodynamic therapy to treat and kill aggressive breast cancer cells.